Cavernous Hemangioma Of Brain: Disease Bioinformatics
A cavernous brain hemangioma is a type of blood vessel malformation the results in blood-filled cavities around the tissues of the brain. Cavernous brain hemangiomas are lesions that arise from the tiny vessels that separate the arterial system from the venous system of the brain. It is also possible that these cavernous hemangiomas are slow growing tumors of capillary blood vessels. The lesions are benign, and no treatment is necessary unless there is evidence of a hemorrhage or the occurrence of seizures. Once there is a hemorrhage of the hemangioma, it tends to happen again, which leads to very rapid neurological decline, as cell function is lost every time there is bleeding into the tissues. When hemorrhaging does occur, the treatment options are to surgically remove the cavernous brain hemangioma, or to treat it with radiation therapy.
Cavernous Hemangioma Of Brain Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Cavernous Hemangioma Of Brain below!
For more information on how to use Laverne, please read the How to Guide.
We have 1537 products for the study of Cavernous Hemangioma Of Brain that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Cavernous Hemangioma Of Brain is also known as Brain Cavernous Hemangioma, Brain Cavernous Hemangiomas, Cerebral Capillary Malformations, Cerebral Cavernous Malformation, Cerebral Cavernous Malformations.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.